These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3283674)

  • 1. [Processing of clonogenic findings in limited dilution. Application to the quantification of autograft depletion].
    Brailly H
    Pathol Biol (Paris); 1988 Jan; 36(1):60-2. PubMed ID: 3283674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The detection of residual clonogenic cells using limited dilution analysis].
    Hirn J; Coullet S; Capitan F
    Pathol Biol (Paris); 1988 Jan; 36(1):63-5. PubMed ID: 3283675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of malignant clonogenic breast cancer cells from human bone marrow.
    Anderson IC; Shpall EJ; Leslie DS; Nustad K; Ugelstad J; Peters WP; Bast RC
    Cancer Res; 1989 Aug; 49(16):4659-64. PubMed ID: 2663144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Culture of leukemic progenitor cells in acute non-T lymphoid leukemia].
    Tamayo E; Deconinck E; Lamy B; Hervé P
    Pathol Biol (Paris); 1988 Jan; 36(1):72-7. PubMed ID: 3283678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Quantitative detection and elimination of neuroblastoma cells in vitro. Comparative study of the efficacy of an immunomagnetic method and lymphokine-activated killer cells].
    Kästli M; Aapro M; Blaser K; Jeannet M; Irlé C
    Schweiz Med Wochenschr; 1987 Nov; 117(46):1832-4. PubMed ID: 3321426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems.
    Roots-Weiss A; Papadimitriou C; Serve H; Hoppe B; Koenigsmann M; Reufi B; Oberberg D; Thiel E; Berdel WE
    Bone Marrow Transplant; 1997 Jun; 19(12):1239-46. PubMed ID: 9208119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of residual disease in acute myeloid leukemia using light density gradients and culture assay.
    Ciaudo M; Marie JP; Ifrah N; Thevenin D; Zittoun R
    Pathol Biol (Paris); 1988 Jan; 36(1):67-71. PubMed ID: 3283676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of a highly clonogenic and multipotential subfraction of adult stem cells from bone marrow stroma.
    Smith JR; Pochampally R; Perry A; Hsu SC; Prockop DJ
    Stem Cells; 2004; 22(5):823-31. PubMed ID: 15342946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and validation of a clinically applicable culture procedure for the generation of interleukin-2 activated natural killer cells in human bone marrow autografts.
    Klingemann HG; Deal H; Reid D; Eaves CJ
    Exp Hematol; 1993 Aug; 21(9):1263-70. PubMed ID: 8330650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A hypo-osmotic medium to disaggregate tumor cell clumps into viable and clonogenic single cells for the human tumor stem cell clonogenic assay.
    Leibovitz A; Liu R; Hayes C; Salman SE
    Int J Cell Cloning; 1983 Dec; 1(6):478-85. PubMed ID: 6672110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal T-cell colony formation in agar culture: an attractive assay to test the T-cell depletion from bone marrow.
    Farcet JP; Beaujean F; Cordonnier C; Pico J; Gourdin MF; Divine M; Bracq C; Bouguet J; Laurent G; Bernard A
    Exp Hematol; 1986 Dec; 14(11):1011-4. PubMed ID: 3536543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of hypothermia to autologous stem cell purging.
    Miyagi K; Yamazaki T; Tsujino I; Takahashi N; Koya Y; Masutani M; Sawada U; Horie T
    Cryobiology; 2001 May; 42(3):190-5. PubMed ID: 11578118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of the ability to purge tumor from murine bone marrow using clonogenic assays.
    Jones RJ; Colvin OM; Sensenbrenner LL
    Cancer Res; 1988 Jun; 48(12):3394-7. PubMed ID: 3285994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentials and drawbacks of the human tumor stem cell assay.
    Shoemaker RH; Wolpert-DeFilippes MK; Venditti JM
    Behring Inst Mitt; 1984 May; (74):262-72. PubMed ID: 6477356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cell cultures in Burkitt's lymphoma. Detection of residual disease and application to autologous graft purging].
    Philip I; Favrot M
    Pathol Biol (Paris); 1988 Jan; 36(1):79-82. PubMed ID: 3283679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
    Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
    Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory activity of endogenous MIP-1 alpha in long-term cultures of human marrow.
    Cashman JD; Eaves AC; Wolpe S; Eaves CJ
    Prog Clin Biol Res; 1994; 389():261-8. PubMed ID: 7700910
    [No Abstract]   [Full Text] [Related]  

  • 18. Bone marrow purging and processing--a review of ancillary effects.
    Gee AP
    Prog Clin Biol Res; 1990; 333():507-21. PubMed ID: 2408064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
    Bregni M; De Fabritiis P; Raso V; Greenberger J; Lipton J; Nadler L; Rothstein L; Ritz J; Bast RC
    Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonogenic and nonclonogenic in vitro chemosensitivity assays.
    Weisenthal LM; Lippman ME
    Cancer Treat Rep; 1985 Jun; 69(6):615-32. PubMed ID: 3893692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.